Cacti Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Cacti Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$305K	Hold	9,000	–	–	0.02%	67
2026 Q1	$271K	Hold	9,000	–	–	0.02%	67
2025 Q4	$284K	Hold	9,000	–	–	0.02%	66
2025 Q3	$165K	Sell	9,000 -1,000	-10%	-$17.6K	0.01%	67
2025 Q2	$168K	Hold	10,000	–	–	0.01%	67
2025 Q1	$151K	Hold	10,000	–	–	0.01%	69
2024 Q4	$223K	Hold	10,000	–	–	0.02%	63
2024 Q3	$177K	Hold	10,000	–	–	0.01%	69
2024 Q2	$163K	Hold	10,000	–	–	0.01%	68
2024 Q1	$166K	Hold	10,000	–	–	0.01%	69
2023 Q4	$105K	Hold	10,000	–	–	0.01%	72
2023 Q3	$102K	Hold	10,000	–	–	0.01%	72
2023 Q2	$75.3K	Hold	10,000	–	–	0.01%	73
2023 Q1	$88.5K	Hold	10,000	–	–	0.01%	73
2022 Q4	$91.2K	Hold	10,000	–	–	0.01%	73
2022 Q3	$81K	Hold	10,000	–	–	0.01%	74
2022 Q2	$75K	Hold	10,000	–	–	0.01%	77
2022 Q1	$94K	Hold	10,000	–	–	0.01%	75
2021 Q4	$80K	Hold	10,000	–	–	0.01%	73
2021 Q3	$97K	Hold	10,000	–	–	0.01%	72
2021 Q2	$104K	Hold	10,000	–	–	0.01%	72
2021 Q1	$115K	Hold	10,000	–	–	0.01%	72
2020 Q4	$96K	Hold	10,000	–	–	0.01%	73
2020 Q3	$88K	Hold	10,000	–	–	0.01%	70
2020 Q2	$127K	Hold	10,000	–	–	0.01%	66
2020 Q1	$85K	Hold	10,000	–	–	0.01%	65
2019 Q4	$100K	Sell	10,000 -10,000	-50%	-$89.3K	0.01%	69
2019 Q3	$149K	Sell	20,000 -666,543	-97%	-$5.11M	0.01%	70
2019 Q2	$6.18M	Sell	686,543 -295,739	-30%	-$3.57M	0.48%	27
2019 Q1	$15.4M	Buy	982,282 +404,378	+70%	+$7.13M	1.24%	25
2018 Q4	$8.91M	Buy	577,904 +64,180	+12%	+$1.32M	0.78%	27
2018 Q3	$10.9M	Buy	+513,724	New	+$11.9M	0.81%	27

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Cacti Asset Management's TEVA Position: Q2 2026 in Review

Cacti Asset Management held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 9,000 shares worth $305K. The position accounts for 0.02% of the portfolio, ranked #67.

Cacti Asset Management first reported a position in TEVA in Q3 2018 and has held it in 32 quarters since. The position peaked at $15.4M in Q1 2019. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Cacti Asset Management held 9,000 shares of Teva Pharmaceuticals worth $305K as of Q2 2026.
Cacti Asset Management left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up 0.02% of Cacti Asset Management's portfolio in Q2 2026, its #67 holding.
Cacti Asset Management first reported a position in Teva Pharmaceuticals in Q3 2018 and has held it in 32 quarters since.
Cacti Asset Management's Teva Pharmaceuticals position peaked at $15.4M in Q1 2019.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Cacti Asset Management's 13F filing for Q2 2026, filed 1 Jul 2026.